CatalystFDA/Bio

AbbVie (ABBV) Reports Positive Phase 3 Results For Etentamig In Multiple Myeloma

Positive Phase 3 data for etentamig in multiple myeloma signals regulatory and commercial upside.

What changed

Positive Phase 3 data for etentamig in multiple myeloma signals regulatory and commercial upside.

Why it matters

Positive Phase 3 data for etentamig in multiple myeloma signals regulatory and commercial upside. — impact context not separately stored; see What changed.

Sources

eodhd